Marco Bruno Morelli

Cardiovascular and metabolic scientist (Ph.D.) with 10+ years across academic and research centers in Italy, the UK, and the US, translating complex preclinical research into clear, evidence-based communication. Author of 25 peer-reviewed publications, first or co-first author on 11, and peer reviewer for Frontiers in Cardiovascular Medicine. Skilled in literature synthesis, manuscript and review writing, congress presentations and panels, and cross-functional work with clinicians and scientific teams.

Senior Researcher at Hospital IRCCS Sant'Orsola (2023-09 – Present)

Cardiac regeneration and cardio-oncology research; lead and co-author on peer-reviewed cardiomyopathy and cardiotoxicity papers; translation of preclinical data for multidisciplinary research area.

Senior Research Associate at Bristol Medical School (THS), University of Bristol (2022-10 – 2023-08)

Translational cardiovascular research within a clinical medical school; cross-functional collaboration with clinical and basic-science teams.

Senior Postdoctoral Researcher at MultiMedica IRCCS (2021-07 – 2022-06)

Cardiovascular and metabolic disease research; literature synthesis, manuscript preparation, and scientific review.

Postdoctoral Researcher at Albert Einstein College of Medicine (2019-08 – 2021-05)

Heart failure and cardiometabolic research; multiple first / co-first-author papers and invited reviews; presenting author at AHA Scientific Sessions.

Postdoctoral Researcher at New York Medical College (2018-06 – 2019-07)

Vascular and renal pharmacology; peer-reviewed publications and international congress abstracts.

Postdoctoral Researcher at University of Texas Medical Branch (2017-04 – 2018-06)

In vivo and in vitro cardiovascular research; scientific writing and data presentation.

Ph.D. in Molecular Pharmacology – University of Ferrara (2015-03)

M.Sc. in Molecular Biology – University of Ferrara (2011-03)